{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:59:46Z","timestamp":1778655586019,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T00:00:00Z","timestamp":1314576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T00:00:00Z","timestamp":1314576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/bmt.2011.162","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T10:54:05Z","timestamp":1314615245000},"page":"706-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation"],"prefix":"10.1038","volume":"47","author":[{"given":"B-M","family":"Svahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Alvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,29]]},"reference":[{"key":"BFbmt2011162_CR1","first-page":"323","volume":"10","author":"T Dufoir","year":"1992","unstructured":"Dufoir T, Saux MC, Terraza B, Marit G, Guessard S, Foulon G et al. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission. Bone Marrow Transplant 1992; 10: 323\u2013329.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011162_CR2","volume-title":"Prospective Payment for Medicare: Report to Congress","author":"R Schweiker","year":"1982","unstructured":"Schweiker R . Prospective Payment for Medicare: Report to Congress. Department of Health and Human Services: Baltimore, MD, 1982."},{"key":"BFbmt2011162_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1200\/JCO.1996.14.5.1413","volume":"14","author":"R Barr","year":"1996","unstructured":"Barr R, Furlong W, Henwood J, Feeny D, Wegener J, Walker I et al. Economic evaluation of allogeneic bone marrow transplantation: a rudimentary model to generate estimates for the timely formulation of clinical policy. J Clin Oncol 1996; 14: 1413\u20131420.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011162_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.bmt.1705078","volume":"36","author":"G de Lissovoy","year":"2005","unstructured":"de Lissovoy G, Hurd D, Carter S, Beatty P, Ewell M, Henslee-Downey J et al. Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease. Bone Marrow Transplant 2005; 36: 539\u2013546.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011162_CR5","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood.V92.11.4047","volume":"92","author":"SJ Lee","year":"1998","unstructured":"Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC . The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood 1998; 92: 4047\u20134052.","journal-title":"Blood"},{"key":"BFbmt2011162_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1200\/JCO.2000.18.1.64","volume":"18","author":"SJ Lee","year":"2000","unstructured":"Lee SJ, Klar N, Weeks JC, Antin JH . Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64\u201371.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011162_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.bmt.1703310","volume":"28","author":"V Mishra","year":"2001","unstructured":"Mishra V, Vaaler S, Brinch L . A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures. Bone Marrow Transplant 2001; 28: 1111\u20131116.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011162_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/01.tp.0000226171.43943.d3","volume":"82","author":"BM Svahn","year":"2006","unstructured":"Svahn BM, Alvin O, Ringden O, Gardulf A, Remberger M . Costs of allogeneic hematopoietic stem cell transplantation. Transplantation 2006; 82: 147\u2013153.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR9","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","volume":"100","author":"BM Svahn","year":"2002","unstructured":"Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002; 100: 4317\u20134324.","journal-title":"Blood"},{"key":"BFbmt2011162_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.bmt.1704108","volume":"32","author":"M Remberger","year":"2003","unstructured":"Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P et al. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II\u2013IV. Bone Marrow Transplant 2003; 32: 217\u2013223.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011162_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","volume":"22","author":"O Ringden","year":"2004","unstructured":"Ringden O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2004; 22: 416\u2013423.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011162_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1399-0039.2008.01148.x","volume":"72","author":"D Hauzenberger","year":"2008","unstructured":"Hauzenberger D, Schaffer M, Ringden O, Hassan Z, Omazic B, Mattsson J et al. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study. Tissue Antigens 2008; 72: 549\u2013558.","journal-title":"Tissue Antigens"},{"key":"BFbmt2011162_CR13","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindelov L et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Blood 1999; 93: 2196\u20132201.","journal-title":"Blood"},{"key":"BFbmt2011162_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.bmt.1703811","volume":"31","author":"P Hentschke","year":"2003","unstructured":"Hentschke P, Barkholt L, Uzunel M, Mattsson J, Wersall P, Pisa P et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant 2003; 31: 253\u2013261.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011162_CR15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BFbmt2011162_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","volume":"78","author":"M Remberger","year":"2004","unstructured":"Remberger M, Svahn BM, Mattsson J, Ringden O . Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation. Transplantation 2004; 78: 122\u2013127.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00007890-199410270-00005","volume":"58","author":"O Ringden","year":"1994","unstructured":"Ringden O, Remberger M, Aschan J, Lungman P, Lonnqvist B, Markling L . Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients. Transplantation 1994; 58: 887\u2013891.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","volume":"73","author":"R Storb","year":"1989","unstructured":"Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Beatty P et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729\u20131734.","journal-title":"Blood"},{"key":"BFbmt2011162_CR19","first-page":"619","volume":"15","author":"O Ringden","year":"1995","unstructured":"Ringden O, Remberger M, Persson U, Ljungman P, Aldener A, Andstrom E et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619\u2013625.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011162_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","volume":"21","author":"K Le Blanc","year":"2007","unstructured":"Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21: 1733\u20131738.","journal-title":"Leukemia"},{"key":"BFbmt2011162_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","volume":"81","author":"O Ringden","year":"2006","unstructured":"Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 1390\u20131397.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR22","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","volume":"21","author":"O Ringden","year":"2007","unstructured":"Ringden O, Uzunel M, Sundberg B, Lonnies L, Nava S, Gustafsson J et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007; 21: 2271\u20132276.","journal-title":"Leukemia"},{"key":"BFbmt2011162_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/TP.0b013e31816a3267","volume":"85","author":"BM Svahn","year":"2008","unstructured":"Svahn BM, Remberger M, Heijbel M, Martell E, Wikstrom M, Eriksson B et al. Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation 2008; 85: 1000\u20131007.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR24","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BFbmt2011162_CR25","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1200\/JCO.2008.20.9692","volume":"27","author":"O Ringden","year":"2009","unstructured":"Ringden O, Labopin M, Ehninger G, Niederwieser D, Olsson R, Basara N et al. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia. J Clin Oncol 2009; 27: 4570\u20134577.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011162_CR26","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","volume":"22","author":"MG Kiehl","year":"2004","unstructured":"Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004; 22: 2816\u20132825.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011162_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7326\/0003-4819-119-3-199308010-00005","volume":"119","author":"DI Marks","year":"1993","unstructured":"Marks DI, Cullis JO, Ward KN, Lacey S, Syzdlo R, Hughes TP et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207\u2013214.","journal-title":"Ann Intern Med"},{"key":"BFbmt2011162_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V94.2.455","volume":"94","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Runde V, Bornhauser M, Blau IW, Basara N et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation. Blood 1999; 94: 455\u2013464.","journal-title":"Blood"},{"key":"BFbmt2011162_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/bmt.2008.239","volume":"42","author":"O Ringden","year":"2008","unstructured":"Ringden O, Okas M, Uhlin M, Uzunel M, Remberger M, Mattsson J . Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Bone Marrow Transplant 2008; 42: 643\u2013648.","journal-title":"Bone Marrow Transplant"},{"issue":"1 Suppl 1","key":"BFbmt2011162_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbmt.2005.09.006","volume":"12","author":"V Rocha","year":"2006","unstructured":"Rocha V, Gluckman E . Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12 (1 Suppl 1): 34\u201341.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011162_CR31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V88.3.795.795","volume":"88","author":"JE Wagner","year":"1996","unstructured":"Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795\u2013802.","journal-title":"Blood"},{"key":"BFbmt2011162_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/bbmt.1999.v5.pm10465099","volume":"5","author":"PA McSweeney","year":"1999","unstructured":"McSweeney PA, Storb R . Mixed chimerism: preclinical studies and clinical applications. Biol Blood Marrow Transplant 1999; 5: 192\u2013203.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011162_CR33","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","volume":"81","author":"KG Blume","year":"1993","unstructured":"Blume KG, Kopecky KJ, Henslee-Downey JP, Forman SJ, Stiff PJ, LeMaistre CF et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood 1993; 81: 2187\u20132193.","journal-title":"Blood"},{"issue":"Supplement 1","key":"BFbmt2011162_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","volume":"14","author":"J Mattsson","year":"2008","unstructured":"Mattsson J, Ringden O, Storb R . Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14 (Supplement 1): 165\u2013170.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011162_CR35","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1200\/JCO.2004.02.189","volume":"22","author":"M Eapen","year":"2004","unstructured":"Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza Jr FR, Ringden O et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004; 22: 4872\u20134880.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011162_CR36","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1097\/01.tp.0000210324.44633.b1","volume":"81","author":"BM Svahn","year":"2006","unstructured":"Svahn BM, Ringden O, Remberger M . Treatment costs and survival in patients with grades III\u2013IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades. Transplantation 2006; 81: 1600\u20131603.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02306.x","volume":"111","author":"P Guardiola","year":"2000","unstructured":"Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. Br J Haematol 2000; 111: 292\u2013302.","journal-title":"Br J Haematol"},{"key":"BFbmt2011162_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1365-2141.2000.01851.x","volume":"108","author":"M Michallet","year":"2000","unstructured":"Michallet M, Tanguy ML, Socie G, Thiebaut A, Belhabri A, Milpied N et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol 2000; 108: 400\u2013407.","journal-title":"Br J Haematol"},{"key":"BFbmt2011162_CR39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/00007890-199811270-00012","volume":"66","author":"P Ljungman","year":"1998","unstructured":"Ljungman P, Aschan J, Lewensohn-Fuchs I, Carlens S, Larsson K, Lonnqvist B et al. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation 1998; 66: 1330\u20131334.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00007890-198504000-00008","volume":"39","author":"T Paulin","year":"1985","unstructured":"Paulin T, Ringden O, Lonnqvist B . Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation 1985; 39: 377\u2013384.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00007890-198703000-00015","volume":"43","author":"T Paulin","year":"1987","unstructured":"Paulin T, Ringden O, Nilsson B, Lonnqvist B, Gahrton G . Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987; 43: 393\u2013398.","journal-title":"Transplantation"},{"key":"BFbmt2011162_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1439-0507.1996.tb00123.x","volume":"39","author":"EE Andstrom","year":"1996","unstructured":"Andstrom EE, Ringden O, Remberger M, Svahn BM, Tollemar J . Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients. Mycoses 1996; 39: 185\u2013193.","journal-title":"Mycoses"},{"key":"BFbmt2011162_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7\u201314.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011162_CR44","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813\u20131821.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2011162_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bmt.2008.355","volume":"43","author":"H Hebart","year":"2009","unstructured":"Hebart H, Klingspor L, Klingebiel T, Loeffler J, Tollemar J, Ljungman P et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant 2009; 43: 553\u2013561.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2011162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2011162","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2011162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:45:42Z","timestamp":1648046742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2011162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,29]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFbmt2011162"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2011.162","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,29]]},"assertion":[{"value":"21 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}